CNR1 and obesity due to melanocortin 4 receptor deficiency: In the quest to develop more specific and safe pharmacological interventions to treat obesity, the recently presented molecular ultrastructure of human CB1 holds potential for newer opportunities for design of novel anti-obesity drugs [328,329].